NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/08/2022
Back to search
Official data from USPTO
XENPOZYME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/08/2022
Trademark type
Combined
Nice classes
5
Filing date
12/23/2020
Registration date
11/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2022
Last transaction
11/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/16/2022
First use in commerce
09/16/2022
Drawing code
3
Owner type
03
Owner location
Cambridge, MA, US
Examiner
SAITO, KIM
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "XENPOZYME" in blue. To the left of and pointing towards the "X" is a green arrow.
Holders and representatives
Holders
G. C. (pessoa física)
Representatives
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancerthrombosisrespiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseasesviral and bacterial infections
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/06/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/06/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/06/2022
IUAF
USE AMENDMENT FILED
09/23/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/23/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/02/2022
EX2G
SOU EXTENSION 2 GRANTED
07/29/2022
EXT2
SOU EXTENSION 2 FILED
07/29/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/29/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2022
EX1G
SOU EXTENSION 1 GRANTED
02/09/2022
EXT1
SOU EXTENSION 1 FILED
02/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/27/2021
PUBO
PUBLISHED FOR OPPOSITION
07/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2021
DOCK
ASSIGNED TO EXAMINER
06/20/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
04/07/2021
ALIE
ASSIGNED TO LIE
04/04/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/05/2021
NWAP
NEW APPLICATION ENTERED
12/26/2020
Continuous trademark protection
Get notified about every new filing that threatens XENPOZYME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.